ChromoGenics AB (publ) is applying for listing of the Company’s shares and warrants (TO1) at Nasdaq First North.
Subscription period: 9th – 24th of February 2017
Liquidation: around March 6, 2017
Listing: around March 23, 2017
ChromoGenics to the stock market
Briefly about ChromoGenics:
ChromoGenics is a global leader within dynamic glas with controllable, optical solutions. The Company’s unique electrochromic technology, ConverLight™, provides dynamic solar control with improved indoor comfort and energy efficiency. In 2016, sales and deliveries to real estate projects in Scandinavia began.
The demand for dynamic glas is driven by, among other factors, an increased focus on sustainability. Market research indicates that the market for dynamic glas will increase drastically over the next couple of years due to energy efficiency issues. ChromoGenics is based in Uppsala and derived from world-leading research at the Ångström laboratory at Uppsala University. The Company has approximately 20 employees.
Download the information brochure here
Download the prospectus here
Download the additional prospectus here
Download the application form here
Download the press release about IPO here
Documents available for inspection
The following documents are available for inspection at the Company’s office (Ullforsgatan 15, 752 28 Uppsala) as well as in electronic form at the Company’s website (www.chromogenics.com):
- Articles of association of ChromoGenics AB (publ)
- Prospectus
- ChromoGenics AB (publ) reviewed financial interim information for the period January-September 2016
- ChromoGenics AB (publ) audited accounts for the financial year of 2014, including the auditor’s report
- ChromoGenics AB (publ) audited accounts for the financial year of 2015, including the auditor’s report
Documents incorporated by reference
The company’s annual reports have been prepared in accordance with the Annual Accounts Act (1995:1554) and The Swedish Accounting Standards Board’s general advice BFNAR 2012:1 (K3), and has been audited by the Company’s auditor. The audit reports for the annual reports of 2014 and 2015 are found on the last page of each annual report and are incorporated in their entirety by reference and form a part of the Prospectus. The financial interim information for 2016 has been established according to the same principles and regulations. The financial interim information has been reviewed by the Company’s auditor. The Company’s interim information for January – September 2016, including the audit report, is incorporated by reference and forms a part of the Prospectus. Below is a reference to the specific documents and pages:
- The financial interim information for the period January – September 2016. The income statement and balance sheet can be found on pages 9 and 10 in the interim financial information, as well as the audit report on page 7.
- The Company’s annual report for the financial year 2015, the income statement (page 6), balance sheet (pages 7-8), note 16 over changes in equity (page 20), accounting principles and disclosures in notes (pages 9-22) together with the audit report (last page).
- The Company’s annual report for the financial year 2014, the income statement (page 6), balance sheet (pages 7-8), note 15 over changes in equity (page 20), accounting principles and disclosures in notes (pages 9-22) together with the audit report (last page).
Link to nordnet:
Link for customers at Skandiabanken:
Link to Avanza:
Log in to your account and select My pages/New issues & Introductions/Other Offers
Others subscribe via Aktieinvest (also with bank ID).
Subscribe for shares in ChromoGenics
For Investors
Rights Issues
CFO & Head of Investor Relations